Showing results (51-60 of 404) with videos related to

Sort By:
Pageof 41
Lung Cancer (Amsterdam, Netherlands)|July 17, 2012
Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: a literature-based meta-analysis of 24 trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Expert Opinion on Drug Safety|August 17, 2011
Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studiesFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Gynecologic Oncology|February 4, 2014
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancerDomenica Lorusso, Fausto Petrelli, Andrea Coinu, et al.
Targeted Oncology|December 1, 2012
Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancerFausto Petrelli, Karen Borgonovo, Veronica Lonati, et al.
The Oncologist|April 26, 2012
The risk for anemia with targeted therapies for solid tumorsSandro Barni, Mary Cabiddu, Paolo Guarneri, et al.
Breast Cancer Research and Treatment|October 15, 2018
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysisAlessandro Inno, Sandro Barni, Antonio Ghidini, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Patient performance status and cancer immunotherapy efficacy: a meta-analysisMelissa Bersanelli, Matteo Brighenti, Sebastiano Buti, et al.
Urology|August 13, 2016
Prognostic Factors of Overall Survival in Upper Urinary Tract Carcinoma: A Systematic Review and Meta-analysisFausto Petrelli, Mohamed Ismail Yasser Hussein, Ivano Vavassori, et al.
Gynecologic Oncology|May 6, 2014
Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysisFausto Petrelli, Agostina De Stefani, Francesco Raspagliesi, et al.
The Oncologist|May 2, 2008
Targeted therapies for the treatment of breast cancer in the post-trastuzumab eraFausto Petrelli, Mary Cabiddu, Marina Elena Cazzaniga, et al.
Pageof 41